Facebook
Twitter
LinkedIn
Forward
Hepatic Ketone Production as the Governing Factor in Determining Fatty Liver and Type 2 Diabetes (NUTRITION 2024 On Demand Collection)
This course is included in the NUTRITION 2024 On Demand Collection.
Originally presented at NUTRITION 2024, ASN's flagship meeting which was held June 29 to July 2 in Chicago, IL.
Speakers
Jeffrey Browning, MD
Professor and Chair, Clinical Nutrition
UT Southwestern Medical Center
Peter Crawford, MD, PhD
Professor of Medicine and Vice Dean for Research, Medical School
Department of Medicine
University of Minnesota
Barbara Gower, PhD
Department Chair and Professor, Department of Nutrition Sciences
The University of Alabama at Birmingham
Eric Plaisance, PhD
Associate Professor and Vice Chair
The University of Alabama at Birmingham
Gerald Shulman, MD, PhD, MACP, MACE, FRCP
George R. Cowgill Professor of Medicine and Cellular and Molecular Physiology
Yale School of Medicine
This activity includes the following presentations:
Welcome and Introductions
Barbara Gower, PhD
Department Chair and Professor, Department of Nutrition Sciences
The University of Alabama at Birmingham
MRS and Mass Spectrometry: Windows into the Inner Workings of Metabolic Disease
Gerald Shulman, MD, PhD, MACP, MACE, FRCP
George R. Cowgill Professor of Medicine and Cellular and Molecular Physiology
Yale School of Medicine
Tracing Hepatic Metabolism in Health and Disease
Jeffrey Browning, MD
Professor and Chair, Clinical Nutrition
UT Southwestern Medical Center
Multi-Dimensional Roles of Ketones in Fuel Metabolism and Therapeutics
Peter Crawford, MD, PhD
Professor of Medicine and Vice Dean for Research, Medical School
Department of Medicine
University of Minnesota
Panel Discussion
Disclosure Policy
It is the policy of the American Society of Nutrition, in compliance with the Standards for Integrity and Independence in Accredited Continuing Education to ensure that education presents learners with only accurate, balanced, and scientifically justified recommendations and protects learners from promotion, marketing, and commercial bias. ASN requires disclosure of all financial interest that the planning committee (including ASN staff) or faculty members have with ineligible companies. All faculty and contributors to this continuing education activity have disclosed any relevant financial relationship that may have direct bearing on the subject matter of this program. Specific disclosure information is in the course materials.
The American Society for Nutrition supports fair and unbiased participation of individuals in its education activities. Any real or potential conflicts of interest must be identified and managed. All relevant financial relationships with commercial interests that directly impact and/or might conflict with ASN activities must be disclosed, or disclosure that no relevant financial relationships exist must be documented. Other relationships that could cause private interests to conflict with professional interests must also be disclosed. This policy is intended to openly identify any potential conflict so that participants in an education activity are able to form their own judgments about the presentation. In addition, disclosure must be made of presentations on drugs or devices or uses of drugs or devices that have not been approved by the Food and Drug Administration.
Speakers
Barbara Gower, PhD, Department Chair and Professor, Department of Nutrition Sciences, The University of Alabama at Birmingham
Disclosures: Cook Keto: Advisory Committee/Board Member (Ongoing)
Eric Plaisance, PhD, Associate Professor and Vice Chair, The University of Alabama at Birmingham
No relevant financial relationship(s) with ineligible companies to disclose.
Jeffrey Browning, MD, Professor and Chair, Clinical Nutrition, UT Southwestern Medical Center
No relevant financial relationship(s) with ineligible companies to disclose.
Peter Crawford, MD, PhD, Professor of Medicine and Vice Dean for Research, Medical School, Department of Medicine, University of Minnesota
Disclosures: Selah Therapeutics: Consultant (Ongoing)
Gerald Shulman, MD, PhD, MACP, MACE, FRCP, George R. Cowgill Professor of Medicine and Cellular and Molecular Physiology, Yale School of Medicine
Disclosures: Aro Biotherapeutics: Consultant (Ongoing), Arrowhead Pharmaceuticals: Speaker/Speaker's Bureau (Terminated, December 18, 2023), AstraZeneca: Consultant (Terminated); Grant/Research Support (Terminated), Bayer AG: Consultant (Ongoing), Betagenon AB: Consultant (Ongoing), DiCerna Pharmaceuticals, Inc.: Consultant (Ongoing), Equator Therapeutics: Consultant (Ongoing); Stock Shareholder (excluding mutual funds) (Ongoing), Esperion Therapeutics: Consultant (Ongoing), Eternygen GmbH: Consultant (Terminated, January 1, 2024), Fortress Biotech: Consultant (Ongoing), Generian Pharmaceuticals: Consultant (Ongoing); Stock Shareholder (excluding mutual funds) (Ongoing), iMetabolic Biopharma Corporation: Consultant (Ongoing); Stock Shareholder (excluding mutual funds) (Ongoing), Janssen: Consultant (Terminated, January 1, 2024); Speaker/Speaker's Bureau (Terminated, January 1, 2024), Kriya Therapeutics,: Consultant (Ongoing), Levels Health: Stock Shareholder (excluding mutual funds) (Ongoing), Mammoth BioSciences, Inc: Consultant (Ongoing), Maze Therapeutics, Inc.: Consultant (Terminated, January 1, 2023); Grant/Research Support (Terminated, January 1, 2023), Merck Pharmaceuticals: Consultant (Ongoing); Grant/Research Support (Ongoing), Novo Nordisk: Consultant (Ongoing), OrsoBio: Stock Shareholder (excluding mutual funds) (Ongoing)
Planners
The following individuals served on the NUTRITION 2024 Scientific Program Committee. This session was included in the scientific program of NUTRITION 2024, ASN's flagship meeting which was held from June 29 to July 2, 2024.
Daniel Hoffman, PhD, Rutgers University
No relevant financial relationship(s) with ineligible companies to disclose.
Debbie Humphries, PhD, MPH, Yale University
No relevant financial relationship(s) with ineligible companies to disclose.
Stephanie Martin, PhD, University of North Carolina at Chapel Hill
No relevant financial relationship(s) with ineligible companies to disclose.
Stefan Pasiakos, PhD, National Institutes of Health, Office of Dietary Supplements
No relevant financial relationship(s) with ineligible companies to disclose.
Drew Sayer, PhD, University of Alabama at Birmingham
No relevant financial relationship(s) with ineligible companies to disclose.
Kathryn Starr, PhD, RD, Duke University School of Medicine and Durham VA Medical Center
No relevant financial relationship(s) with ineligible companies to disclose.
Krista Zanetti, PhD, RD, National Institutes of Health
No relevant financial relationship(s) with ineligible companies to disclose.
Staff
Michelle Crispino, CAE, DES, American Society for Nutrition
No relevant financial relationship(s) with ineligible companies to disclose.
Gwen Twillman, American Society for Nutrition
No relevant financial relationship(s) with ineligible companies to disclose.
Continuing education credit is not available for this activity. A Certificate of Attendance can be downloaded by learners who complete the course.
Available Credit
- 1.50 Attendance
Learners are eligible to download a Certificate of Attendance upon activity completion. A Certificate of Attendance confirms the learner has completed the activity and does not confer any continuing education credit to the learner from ASN.